Investigación Biomédica y Sanitaria
MEDONLINE
Universidad de Sevilla
Sevilla, EspañaPublikationen in Zusammenarbeit mit Forschern von Universidad de Sevilla (5)
2022
-
Adverse events: an expensive and avoidable hospital problem
Annals of Medicine, Vol. 54, Núm. 1, pp. 3157-3168
-
Prevalence, characteristics, and impact of adverse events in 34 Madrid hospitals. The ESHMAD study
European Journal of Clinical Investigation, Vol. 52, Núm. 12
2019
-
New markers for human ovarian cancer that link platinum resistance to the cancer stem cell phenotype and define new therapeutic combinations and diagnostic tools
Journal of Experimental and Clinical Cancer Research, Vol. 38, Núm. 1
2015
-
Efficacy of CDK4 inhibition against sarcomas depends on their levels of CDK4 and p16ink4 mRNA
Oncotarget, Vol. 6, Núm. 38, pp. 40557-40574